Altered Iron Metabolism and Ferroptosis in Polycystic Ovary Syndrome: Insights from a Meta-Analysis and Case-Control Study in Pregnant Women - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Altered Iron Metabolism and Ferroptosis in Polycystic Ovary Syndrome: Insights from a Meta-Analysis and Case-Control Study in Pregnant Women

  • By

  • Tianjing Wang

  • Weihuan Hu

  • Jue Zhou

  • Leyi Fu

  • Ningning Xie

  • Feng Yun

  • Jinlan Piao

  • Jing Lin

  • Danqing Chen

  • Fan Qu

  • Fangfang Wang

  • November 28, 2025

Share

  • 1

    Polycystic ovary syndrome (PCOS) affects 7-12% of women of reproductive age and is linked to various adverse pregnancy outcomes.

  • 2

    Iron metabolism alterations, including elevated serum ferritin and reduced hepcidin levels, are observed in women with PCOS.

  • 3

    Ferroptosis, a form of cell death linked to oxidative stress, may play a role in the pathogenesis of PCOS and its reproductive complications.

  • 4

    The study included a meta-analysis and a case-control study to investigate the relationship between ferroptosis biomarkers and PCOS.

  • 5

    Findings suggest that understanding ferroptosis could lead to novel therapeutic strategies for managing ovulation in PCOS.

Original Source(s)

Related Content